Contravisory Investment Management’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-6,498	Closed	-$251K	–	436
2024 Q4	$251K	Buy	+6,498	New	+$251K	0.05%	203